The Max Planck Institute for Biological Cybernetics investigates information processing in the brain. The Institute uses experimental, theoretical and computational methods to study perception, memory, decision-making, motor performance and more, and to develop appropriate recording and imaging techniques. The Institute is multidisciplinary, has...
The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...
The German Center for Neurodegenerative Diseases (DZNE) is a world-leading internationally oriented research center, committed to discovering new approaches to prevent and treat neurodegenerative diseases. To this end, researchers at ten DZNE sites across Germany pursue a translational and interdisciplinary strategy comprising five...
Preply is an online platform, where tutors and students are connected for learning languages. Preply is looking for dedicated, enthusiastic, and passionate online English teachers to coach, tutor, and help students achieve their language learning goals. With Preply, you can...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA...
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our...
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA people are striving to...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA people are striving to...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA people are striving to...
The Max Planck Institute for Biological Cybernetics investigates information processing in the brain. The Institute uses experimental, theoretical and computational methods to study perception, memory, decision-making, motor performance and more, and to develop appropriate recording and imaging techniques. The Institute is multidisciplinary, has...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA people are striving to...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA people are striving to...
Salary 35.000 - 50.000 EUR per year Check this offer on germantechjobs.deRequirements:- You should bring this with you:- Strong understanding of JavaScript, HTML5, CSS, Sass, Twig, and PHP- Experience building modular and reusable component libraries- Experience with RESTful APIs and GraphQL backends- Experience...
Salary 35.000 - 50.000 EUR per year Check this offer on germantechjobs.deRequirements:- You should bring this with you:- Strong understanding of JavaScript, HTML5, CSS, Sass, Twig, and PHP- Experience building modular and reusable component libraries- Experience with RESTful APIs and GraphQL backends- Experience...
Salary 35.000 - 50.000 EUR per year Check this offer on germantechjobs.deRequirements:- You should bring this with you:- Experience in WordPress and ideally another CMS (like Craft, Drupal, etc)- Experience in programming PHP (OOP and procedural) and JavaScript- Experience with WooCommerce or comparable...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA people are striving to...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA people are striving to...
Design. Progress. Together. CureVac AG is a global biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on prophylactic vaccines, innovative cancer immunotherapies and protein-based therapies. Currently, about 600 RNA people are striving to...
